NCT04688528
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
- Locations
-
- ZOL Genk, Limburg, Belgium
- Jessa Ziekenhuis Hasselt, Limburg, Belgium
- OLV Aalst Aalst, Belgium
- UCL Saint-Luc Brussels, Belgium
Clinical trial condition
Squamous Cell Carcinoma of Head and Neck
Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.
98 public trials
32 recruiting studies
Squamous Cell Carcinoma of Head and Neck trial results
NCT05280314
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
- Locations
-
- Yale New Haven, Connecticut, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Massey Cancer Center Richmond, Virginia, United States
- Melanoma Institute Australia The Uiniversity of Sydney, and Royal North Shore Hospital Sydney, New South Wales, Australia
Not yet recruiting
Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC
NCT07509099
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not yet recruiting
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
NCT07623642
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China
Not yet recruiting
Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC
NCT07400094
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
- Locations
-
- P.A. Hertsen Moscow Oncology Research Institute Moscow, Russia
Not yet recruiting
The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC
NCT06895369
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
- Locations
-
- Sir Run Run Shaw Hospital Hanzhou, Zhejiang, China
Not yet recruiting
Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)
NCT06647563
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
Not specified
Not yet recruiting
PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma
NCT06125223
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more
- Locations
-
Not specified
Active, not recruiting
Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
NCT06557889
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
- Locations
-
- CHU Amiens Amiens, France
- Institut Sainte Catherine Avignon, France
- Chu Bordeaux - Hopital Saint André Bordeaux, France
- Centre Jean Perrin Clermont-Ferrand, France
Active, not recruiting
A Study of SI-B001+SI-B003± Chemotherapy in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma
NCT05668858
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
- Locations
-
- Shanghai Oriental Hospital Shanghai, Shanghai Municipality, China